Currently, there are 2 key substances at the heart of body care:

A GLP-1 Receptor Agonist designed to mimic the natural "fullness" hormone in the body.

Mimics both GLP-1 and GIP hormones simultaneously for a comprehensive action covering both hunger control and the metabolism system.

Differences in the mechanisms of the two substances

Ask for more information / Free consultation

Individuals with a BMI of 25.0 or higher.

Individuals with a BMI of 25.0 or higher.

Those who want to reduce fatty liver

Those who want to reduce fatty liver

People with

"Food Craving" behavior"

People with "Food Craving" behavior"

Those experiencing a "Weight Plateau"

Those experiencing a "Weight Plateau"

People with insulin resistance or high blood sugar levels

Insulin resistance or high blood sugar levels

Working-age people with a rushed lifestyle

Working-age people with a rushed lifestyle

Semaglutide

  • Cardiovascular Protection: Medical studies confirm it helps reduce the risk of ischemic heart disease.
  • Long-term Blood Sugar Control: Helps the pancreas function better and reduces blood sugar accumulation.
  • Reduced Inflammation: Helps reduce various inflammations in the body caused by obesity.

Tirzepatide

  • Insulin Resistance Recovery: The GIP mechanism helps body cells respond excellently to insulin again.
  • Fatty Liver Reduction: Highly effective in reducing fat accumulation in liver cells, improving liver function, and reducing inflammation risk.
  • Balancing Blood Fat & Diabetes: Effectively reduces blood sugar and "bad" fat (including triglycerides) faster and more clearly than single-mechanism actions.

Overall Health Outcomes

Lower Blood Pressure

As weight and excess fat decrease, blood vessel pressure returns to normal

Better Sleep Quality

Reduces the risk of sleep apnea due to reduced fat around the neck area.

Joint Mobility

Reduces the weight-bearing burden on knees and ankles.

Ask for more information / Free consultation

Groups who should NOT use (Contraindications)

  • Family or personal history of specific diseases: Medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome.
  • Pregnant and breastfeeding women: Currently no safety certification for this group; it is recommended to stop use at least 2 months before planning pregnancy.
  • Those with pancreatic inflammation: Patients with a history of pancreatitis should consult a doctor before consideration.
  • Those with gallbladder problems: Rapid weight loss from these substances may increase the risk of gallstones in some cases.
  • Those with kidney problems: Patients with impaired renal function or chronic kidney disease require close monitoring by a doctor due to potential side effects related to dehydration.
  • Nausea and Queasiness: Often occurs during the "Dose Escalation" period. Recommendation: Eat smaller meals and avoid greasy/fatty foods.
  • Constipation or Diarrhea: The body usually adjusts within 2-4 weeks. Drink plenty of water and consume dietary fiber to relieve symptoms.
  • Hypoglycemia (Low Blood Sugar): Mostly occurs in those using other diabetes medications concurrently. A doctor must adjust the medication dosage appropriately.

Additional contact channels WhatApp

Ask for more information / Free consultation

เว็บไซต์นี้มีการใช้งานคุกกี้ เพื่อเพิ่มประสิทธิภาพและประสบการณ์ที่ดีในการใช้งานเว็บไซต์ของท่าน ท่านสามารถอ่านรายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว and นโยบายคุกกี้
Powered By MakeWebEasy Logo MakeWebEasy